Chk1 suppressed cell death

Cell Division

Volumn 5, Issue , 2010, Pages

  Meuth, Mark ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956472414     PISSN: None     EISSN: 17471028     Source Type: Journal    
DOI: 10.1186/1747-1028-5-21     Document Type: Review

References (52)

1. Harper JW, Elledge SJ. The DNA damage response: ten years after. Mol Cell 2007, 28:739-745. 10.1016/j.molcel.2007.11.015, 18082599.
2. Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 2001, 7:683-694. 10.1016/S1097-2765(01)00214-3, 11463392.
3. Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 2001, 7:673-682. 10.1016/S1097-2765(01)00213-1, 11463391.
4. Yu J, Zhang L, Hwang PM, Rago C, Kinzler KW, Vogelstein B. Identification and classification of p53-regulated genes. Proc Natl Acad Sci USA 1999, 96:14517-14522. 10.1073/pnas.96.25.14517, 24468, 10588737.
5. Zhao H, Piwnica-Worms H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol 2001, 21:4129-4139. 10.1128/MCB.21.13.4129-4139.2001, 87074, 11390642.
6. Zhao H, Watkins JL, Piwnica-Worms H. Disruption of the checkpoint kinase1/cell division cycle 25A pathway abrogates ionizing radiation-inducd S and G2 checkpoints. Proc Natl Acad Sci USA 2002, 99:14795-14800. 10.1073/pnas.182557299, 137498, 12399544.
7. Maya-Mendoza A, Petermann E, Gillespie DA, Caldecott KW, Jackson DA. Chk1 regulates the density of active replication origins during the vertabrate S phase. EMBO J 2007, 26:2719-2731. 10.1038/sj.emboj.7601714, 1888675, 17491592.
8. Zachos G, Rainey MD, Gillespie DA. Chk1-dependent S-M checkpoint delay in vertebrate cells is linked to maintenance of viable replication structures. Mol Cell Biol 2005, 25:563-574. 10.1128/MCB.25.2.563-574.2005, 543419, 15632059.
9. Sorensen CS, Hansen LT, Dziegielewski J, Syljuasen RG, Lundin C, Bartek J, Helleday T. The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat Cell Biol 2005, 7:195-201. 10.1038/ncb1212, 15665856.
10. Falck J, Malland N, Syljuasen RG, Bartek J, Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 2001, 410:842-847. 10.1038/35071124, 11298456.
11. Byun TS, Pacek M, Yee MC, Walter JC, Cimprich KA. Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint. Genes Dev 2005, 19(9):1040-1052. 10.1101/gad.1301205, PMC1091739, 15833913.
12. Zou L, Elledge SJ. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 2003, 300:1542-1548. 10.1126/science.1083430, 12791985.
13. Bermudez VP, Lindesey-Boltz LA, Cesare AJ, Mainwa J, Griffith JD, Hurwitz J, Sancar A. Loading of the human 9-1-1 checkpoint complex onto DNA by the checkpoint clamp holder hRad17-replication factor C complex in vitro. Proc Natl Acad Sci USA 2003, 100:1633-1638. 10.1073/pnas.0437927100, 149884, 12578958.
14. Zou L, Liu D, Elledge SJ. Replication protein A-mediated recruitment and activation of Rad17 cpmplexes. Proc Natl Acad Sci USA 2003, 100:13827-13832. 10.1073/pnas.2336100100, 283506, 14605214.
15. Delacroix S, Wagner JM, Kobayashi M, Yamamoto K, Karnitz LM. The Rad9-Hus1-Rad1 (9-1-1) clamp activates checkpoint signaling via TopBP1. Genes Dev 2007, 21(12):1472-1477. 10.1101/gad.1547007, PMC1891424, 17575048.
16. Lee J, Kumagi A, Dunphy WG. The Rad9-Hus1-Rad1 checkpoint clamp regulates interaction of TopBP1 with ATR. J Biol Chem 2007, 282:28036-28044. 10.1074/jbc.M704635200, 17636252.
17. Kumagi WG, Dunphy WG. Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts. Mol Cell 2000, 6:839-849. 10.1016/S1097-2765(05)00092-4, 11090622.
18. Chini CCS, Chen J. Claspin, a regulator of Chk1 in DNA replication stress pathway. DNA Repair 2004, 3:1033-1037. 10.1016/j.dnarep.2004.03.001, 15279790.
19. Rai R, Dai H, Multani AS, Li K, Chin K, Gray J, Lahad JP, Liang J, Mills GB, Meric-Bernstam F, et al. BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer. Cancer Cell 2006, 10:145-157. 10.1016/j.ccr.2006.07.002, 1557410, 16872911.
20. Collis SJ, Ciccia A, Deans AJ, Horejsi Z, Martin JS, Maslen SL, Skehel M, Elledge SJ, West SC, Boulton SJ. FANCM and FAAP24 function in ATR-mediated Checkpoint signaling independently of the Fanconi anemia core complex. Mol CEll 2008, 32:313-324. 10.1016/j.molcel.2008.10.014, 18995830.
21. Gong Z, Kim J-E, Leung CCY, Glover JNM, Chen J. Bach1/FancJ acts with TopBP1 and participates early in DNA replication checkpoint control. Mol Cell 2010, 37:438-446. 10.1016/j.molcel.2010.01.002, 20159562.
22. Smith KD, Fu MA, Brown EJ. Tim-Tipin dysfunction creates an undispensible reliance on the ATR-Chk1 pathway for continued DNA synthesis. J Cell Biol 2009, 187:15-23. 10.1083/jcb.200905006, 2762102, 19805627.
23. MacDougall CA, Byun TS, Van C, Yee MC, Cimprich KA. The structural determinants of checkpoint activation. Genes Dev 2007, 21(8):898-903. 10.1101/gad.1522607, PMC1847708, 17437996.
24. Van C, Yan S, Michael WM, Waga S, Cimprich KA. Continued primer synthesis at stalled replication forks contributes to checkpoint activation. J Cell Biol 2010, 189:233-246. 10.1083/jcb.200909105, 20385778.
25. Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, Lukas J, Jackson SP. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol 2006, 8:37-45. 10.1038/ncb1337, 16327781.
26. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, Luo G, Carattini-Rivera S, DeMayo F, Bradley A, et al. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev 2000, 14(12):1448-1459. 10.1101/gad.14.12.1448, PMC316686, 10859164.
27. Takai H, Tominaga K, Motoyama N, Minamishima YA, Nagahama H, Tsukiyama T, Ikeda K, Nakayama K, Nakanishi M, Nakayama K. Aberrant cell cycle checkpoint function and early embryonic death in Chk1-/- mice. Genes Dev 2000, 14(12):1439-1447. 10.1101/gad.14.12.1439, PMC316691, 10859163.
28. Zachos G, Rainey MD, Gillespie DA. Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects. EMBO J 2003, 22:713-723. 10.1093/emboj/cdg060, 140744, 12554671.
29. Cho SH, Toouli CD, Fujii GH, Crain C, Parry D. Chk1 is essential for tumor cell viability following activation of the replication checkpoint. Cell Cycle 2005, 4:131-139.
30. Rodriguez R, Meuth M. Chk1 and p21 cooperate to prevent apoptosis during DNA replication fork stress. Mol Biol Cell 2006, 17:402-412. 10.1091/mbc.E05-07-0594, 1345677, 16280359.
31. Sidi S, Sanda T, Kennedy RD, Hagen AT, Jette CA, Hoffmans R, Pascual J, Imamura S, Kishi S, Amatruda JF, et al. Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3. Cell 2008, 133:2110-2118.
32. Gagou ME, Zuazua-Villar P, Meuth M. Enhanced H2AX phosphorylation, DNA replication fork arrest, and cell death in the absence of Chk1. Mol Biol Cell 2010, 21:739-752. 10.1091/mbc.E09-07-0618, 2828961, 20053681.
33. Myers K, Gagou ME, Zuazua-Villar P, Rodriguez R, Meuth M. ATR and Chk1 suppress a caspase-3-dependent apoptotic response following DNA replication stress. PLoS Genet 2009, 5:e1000324. 10.1371/journal.pgen.1000324, 2607051, 19119425.
34. Stracker TH, Morales M, Couto SS, Hussein H, Petrini JH. The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complex. Nature 2007, 447:218-221. 10.1038/nature05740, 17429352.
35. Westphal CH, Rowan S, Schmaltz C, Elson A, Fisher DE, Leder P. Atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat Genet 1997, 16:397-401. 10.1038/ng0897-397, 9241281.
36. Kumar S. Caspase-2 in apoptosis, the DNA damage response and tumour suppression: enigma no more. Nat Rev Cancer 2009, 9:897-903. 10.1038/nrc2745, 19890334.
37. Rodriguez R, Gagou ME, Meuth M. Apoptosis induced by replication inhibitors in Chk1-depleted cells is dependent upon the helicase cofactor Cdc45. Cell Death Differ 2008, 15:889-898. 10.1038/cdd.2008.4, 18239674.
38. Aparicio T, Guillou E, Coloma J, Montoya G, Mendez J. The human GINS complex associates with Cdc45 and MCM and is essential for DNA replication. Nucl Acids Res 2009, 37:2087-2095. 10.1093/nar/gkp065, 2673421, 19223333.
39. Bauerschmidt C, Pollok S, Kremmer E, Nasheuer H-P, Grosse F. Interactions of human Cdc45 with the Mcm2-7 complex, the GINS complex, and DNA polymerases d and e during S phase. Genes Cells 2007, 12:745-758.
40. Marti TM, Hefner E, Feeney L, Natale V, Cleaver JE. H2AX phosphorylation within the G1 phase after UV irradiation depends upon nucleotide excision repair and not double-strand breaks. Proc Natl Acad Sci USA 2006, 103:9891-9896. 10.1073/pnas.0603779103, 1502549, 16788066.
41. Lu C, Zhu F, Cho Y-Y, Tang F, Zykove T, Ma W, Bode AM, Dong Z. Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. Mol Cell 2006, 23:121-132. 10.1016/j.molcel.2006.05.023, 2227311, 16818236.
42. Cook PJ, Ju BG, Telese F, Wang X, Glass CK, Rosenfeld MG. Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions. Nature 2009, 458:591-596. 10.1038/nature07849, 2692521, 19234442.
43. Din S, Brill SJ, Fairman MP, Stillman B. Cell-cycle regulated phosphorylation of DNA replication factor A from human and yeast cells. Genes Dev 1990, 4(6):968-977. 10.1101/gad.4.6.968, 2200738.
44. Zou Y, Liu Y, Wu X, Shell SM. Functions of human replication protein A (RPA): from DNA replication to DNA damage and stress responses. J Cell Physiol 2006, 208:267-273. 10.1002/jcp.20622, 16523492.
45. Shi W, Feng Z, Zhang J, Gonzalez-Suarez I, Vanderwaal RP, Wu X, Powell SN, Roti Roti JL, Gonzalo S, Zhang J. The role of RPA2 phosphorylation in homologous recombination in response to replication arrest. Carcinogenesis 2010, 31:994-1002. 10.1093/carcin/bgq035, 20130019.
46. Lam MH, Liu Q, Elledge SJ, Rosen JM. Chk1 is haploinsufficient for multiple functions critical to tumor suppression. Cancer Cell 2004, 6:45-59. 10.1016/j.ccr.2004.06.015, 15261141.
47. Verlinden L, Vanden Bempt I, Eelen G, Drijkoningen M, Verlinden I, Marchal K, De Wolf-Peeters C, Christiaens MR, Michiels L, Bouillon R, et al. The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor/progesterone receptor/HER-2 breast carcinomas. Cancer Research 2007, 67:6574-6581. 10.1158/0008-5472.CAN-06-3545, 17638866.
48. Hammond EM, Dorie MJ, Giaccia AJ. Inhibition of ATR leads to increased sensitivity to hypoxia/reoxygenation. Cancer Research 2004, 64:6556-6562. 10.1158/0008-5472.CAN-04-1520, 15374968.
49. Tse AN, Rendahl KG, Sheikh T, Cheema H, Aardalen K, Embry M, Ma S, Moler EJ, Ni ZJ, Lopes de Menezes DE, et al. CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo. Clin Cancer Res 2007, 13:591-602. 10.1158/1078-0432.CCR-06-1424, 17255282.
50. Fuse E, Tanii H, Kurata N, Kobayashi H, Shimada Y, Tamura T, Sasaki Y, Y T, Lush RD, Headlee D, et al. Unpredicted clinical pharmacology of UCN-01 caused by specific binding to human alpha1-acid glycoprotein. Cancer Research 1998, 58:3248-3253.
51. Janetka JW, Ashwell S. Checkpoint kinase inhibitors: a review of the patent literature. Expert Opin Ther Pat 2009, 19:165-197. 10.1517/13543770802653622, 19441917.
52. Chen CC, Kennedy RD, Sidi S, Look AT, D'Andrea AA. Chk1 inhibition as a strategy for targeting fanconi anemia (FA) DNA repair deficient tumors. Mol Cancer 2009, 8:24. 10.1186/1476-4598-8-24, 2672921, 19371427.